NanoMedSyn
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
15 Av Charles Flahault, Montpellier, Que...Phone Number
+33 411759617Website
www.nanomedsyn.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About NanoMedSyn
NanoMedSyn specializes in developing AMFA glycoligands that target the mannose 6-phosphate receptor (M6PR) for precise intracellular delivery of therapeutics. Their technology enables selective lysosomal addressing of disease-driving antigens for degradation, creating new mechanisms of action for major therapeutic classes. The company focuses on therapeutic antibodies and nanoparticles to enhance the delivery of biologics and enzyme replacement therapies for rare metabolic diseases. By unlocking controlled intracellular routing, NanoMedSyn aims to advance drug discovery and treatment options for a wide range of pathologies.Explore more
NanoMedSyn Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NanoMedSyn your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at NanoMedSyn
Click to see if NanoMedSyn had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if NanoMedSyn is spiking on competitors!
Product Launch: Get notified when NanoMedSyn launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if NanoMedSyn has recently received funding, and reach out quickly before it becomes old news!
NanoMedSyn, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once NanoMedSyn has new funding data
Earning: See what the market has to say on NanoMedSyn recently announced quarterly report
Recommended Actions
Find VP level buyers at NanoMedSyn
Find 3 more new buyers
Company Profile Activity
Activity Insights
NanoMedSyn is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NanoMedSyn is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NanoMedSyn.
NanoMedSyn Tech Stack
A closer look at the technologies used by NanoMedSyn
See more technologies
NanoMedSyn News & Media
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding NanoMedSyn
Sign Up For FreeTo access detailed company insights
NanoMedSyn specializes in developing AMFA glycoligands that target the mannose 6-phosphate receptor (M6PR) for precise intracellular delivery of therapeutics. Their technology enables selective lysosomal addressing of disease-driving antigens for degradation, creating new mechanisms of action for major therapeutic classes. The company focuses on th... Read More
